Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group (Q33379949)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q40592168)
(Q74084050)
(Q88032966)
(P304) 508-514
(P407) (Q1860)
(P433) 3
(P478) 113
(P577) Friday, August 1, 2008
(P921) (Q42824440)
(Q268713)
(P1433) (Q326041)
(P1476) "Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group" (language: en)
(P2093) Stephen M Ansell
David J Inwards
Kendrith M Rowland
Patrick J Flynn
Roscoe F Morton
Dennis F Moore
Paul J Kurtin
Christine Allmer
Thomas E Witzig
(P2860) (Q36944390)
(Q33375798)
(Q29618608)
(Q40202733)
(Q33372761)
(Q36568861)
(Q33366976)
(Q33366403)
(Q33361458)
(Q28263800)
(Q33773306)
(Q28239256)
(Q46412217)
(Q44966920)
(Q44551425)
(Q80258993)
(Q25938997)
other details
description scientific article

External Links